Predictor | Controlled hypertension, No. (%) | Unadjusted OR (95% CI) | Adjusted OR (95%CI) | |
---|---|---|---|---|
No | Yes | |||
Sex | ||||
Male | 224 (44) | 290 (56) | Reference | – |
Female | 336 (41) | 483 (59) | 1.11 (0.89–1.39) | |
Age in years | ||||
< 65 | 332 (41) | 475 (59) | 1.10 (0.88–1.37) | – |
≥ 65 | 228 (43) | 298 (58) | Reference | |
Ethnicity | ||||
Non-white | 338 (45) | 420 (55) | Reference | Ref. |
White | 222 (39) | 353 (61) | 1.28 (1.03–1.59) | 1.39 (1.08–1.79) |
Post-primary Education | ||||
No | 109 (53) | 96 (47) | Reference | Ref. |
Yes | 451 (40) | 677 (60) | 1.70 (1.26–2.30) | 1.72 (1.26–2.35) |
Civil status | ||||
Single | 241 (42) | 330 (58) | Reference | – |
Married/Partner | 319 (42) | 443 (58) | 1.01 (0.81–1.26) | |
Paid job | ||||
No | 222 (43) | 300 (58) | Reference | – |
Yes | 338 (42) | 473 (58) | 0.97 (0.77–1.20) | |
Obesity | ||||
Yes | 131 (49) | 134 (51) | Reference | Ref. |
No | 429 (40) | 639 (60) | 1.46 (1.11–1.91) | 1.43 (1.09–1.89) |
Diabetes | ||||
Yes | 89 (43) | 118 (57) | Reference | – |
No | 471 (42) | 655 (58) | 1.05 (0.78–1.42) | |
Coronary heart disease | ||||
Yes | 79 (43) | 106 (57) | Reference | – |
No | 481 (42) | 667 (58) | 1.03 (0.75–1.42) | |
On anti-hypertensive pharmacological treatment | ||||
===No | 52 (45) | 63 (55) | Reference | Ref. |
Yes, non-adherent | 281 (45) | 341 (55) | 1.00 (0.7–1.5) | 1.06 (0.70–1.59) |
Yes, adherent | 227 (38) | 369 (62) | 1.34 (0.90–2.0) | 1.35 (0.90–2.05) |
Health area | ||||
JAE | 101 (35) | 191 (65) | Reference | Ref. |
Finlay | 164 (47) | 187 (53) | 0.60 (0.45–0.81) | 0.75 (0.54–1.04) |
Grimau | 135 (39) | 209 (61) | 0.82 (0.60–1.11) | 1.11 (0.78–1.56) |
Moncada | 160 (46) | 186 (54) | 0.62 (0.46–0.83) | 0.71 (0.52–0.98) |